Biological Factors: News and Research on Antigens, Tumor-Associated, Carbohydrate

MeSH tree: D23.101.140.075

Zenocutuzumab shows clinical benefit in rare bile duct cancer

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...

page 1 from 3